Skip to main navigation
  • News & Investors

    News & Investors

    • Press Releases
    • Financial Events
    • Scientific Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Analyst Coverage
    • Request Information
    • Investor FAQs
    • Investor Contact
  • Contact Us
Celsion
  • TECHNOLOGY
    • LTSL
    • TheraPlas
    • TheraSilence
  • PRODUCTS
    • ThermoDox
    • GEN-1
  • PIPELINE
    • Clinical Studies
    • Pre-clinical Programs
  • DISEASES
  • PUBLICATIONS
  • ABOUT US
    • Leadership
    • Board of Directors
    • Corporate Governance
Select Page

SEC Filings

    Investor Relations

    • News & Investors
    • Press Releases
    • Financial Events
    • Scientific Presentations
    • Corporate Governance
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
    • Stock Information
    • Analyst Coverage
    • Request Information
    • Investor FAQs
    • Investor Contact

SEC Filings

Filing date Form Description View
May 16, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001493152-22-013519.pdf
0001493152-22-013519.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
May 16, 2022 10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML
0001493152-22-013522.pdf
0001493152-22-013522.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Apr 29, 2022 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
0001493152-22-011449.pdf
0001493152-22-011449.xls
Apr 12, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001437749-22-008740.pdf
0001437749-22-008740.xls
Apr 11, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001437749-22-008664.pdf
0001437749-22-008664.xls
Apr 8, 2022 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
0001493152-22-009383.pdf
0001493152-22-009383.xls
Apr 7, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001493152-22-009363.pdf
0001493152-22-009363.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Mar 31, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001493152-22-008270.pdf
0001493152-22-008270.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Mar 31, 2022 10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML
0001493152-22-008277.pdf
0001493152-22-008277.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Mar 16, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001493152-22-006947.pdf
0001493152-22-006947.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

    Shareholder Tools

    • Printed Materials
    • Email Alerts
    • Downloads
    • RSS
    • Print
    • Search

    • Facebook
    • LinkedIn
    • Twitter
    • RSS

Celsion
Home

Technology

Products

Pipeline

Disease

Publications

News & Investors

About Us

Careers

Privacy Policy

LinkedIn

    ThermoDox is a registered trademark of Celsion Corporation.
    TheraPlas and TheraSilence are trademarks of Celsion Corporation.
    Avastin is a registered trademark of Genentech, Inc.
    Copyright © 2022 Celsion Corporation. All rights reserved.

    • Twitter
    • Facebook
    • LinkedIn
    Share This
    • Twitter
    • Google+
    • Facebook
    • LinkedIn